AU-24943

N/A

Report date: 2025/01/26 16:20:44

Base Information

Drug NameAU-24943
Drug Alias Namedual PD-L1/A2aR antagonists (Aurigene Oncology)dual PD-L1 checkpoint inhibitor/A2aR checkpoint inhibitor (Aurigene Oncology)AU-24943
ClassificationBiologics
Mechanisms of ActionProgrammed cell death protein 1 blockersAdenosine A2a receptor antagonists
TargetsProgrammed cell death protein 1Adenosine A2a receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAurigene Oncology Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A